Nordic Bioscience

Company snapshot

Nordic Bioscience is the leading expert in extracellular matrix (ECM) research. We support some of the largest pharmaceutical companies in preclinical and clinical research with three decades of experience in biomarker development. With more than 750 peer-reviewed publications, our science-driven approach has been the evolving force behind our decades of success. Through our Nordic ProteinFingerPr

• 5 active pipeline program(s) linked via ClinicalTrials.gov.
• 5 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Nordic Bioscience. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Nordic Bioscience.

1. Jun 8, 2026 Clinical update

   CSCI-SKT-B1001 — Phase 2

2. Jun 8, 2026 Clinical update

   Leukine for Ovarian cancer — Phase 2

3. May 26, 2026 Clinical update

   SMC021 Oral Calcitonin — Phase 3

4. May 26, 2026 Clinical update

   SMC021 Oral calcitonin — Phase 3

5. May 26, 2026 Clinical update

   Teverelix TFA — Phase 2

View all clinical trial activity →

• What is Nordic Bioscience?

  Nordic Bioscience A/S is a pharma organization headquartered in Herlev, DK. Primary therapeutic focus areas include Osteoarthritis, Osteoporosis, Ovarian cancer, Advanced prostate cancer, Atopic dermatitis. NovaPharmaNews links 5 clinical program(s), 0 drug profile(s), and 0 pate

• Is Nordic Bioscience publicly traded?

  Nordic Bioscience appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Nordic Bioscience develop or market?

  We link 10 drug profile(s) where Nordic Bioscience is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/nordic-group-b-v#company-drugs.

• What are the latest developments for Nordic Bioscience?

  In the last 12 months our linked public records show 5 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Nordic Bioscience focus on?

  Nordic Bioscience focuses on Osteoarthritis, Osteoporosis, Ovarian cancer based on our analysis of their pipeline programs and drug development activities.